Atlas Trials

Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer

Clinical trial NCT06585007 · RECRUITING

Trial details

NCT number
NCT06585007
Sponsor
Universitaire Ziekenhuizen KU Leuven
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Castration-resistant Prostate CancerOligoprogressive
Start date
2023-12-19
Primary completion
2029-01-20
Enrollment
246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.